🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Level Biotechnology Inc. (TPEX:3118)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.40
-0.50 (-1.73%)
Nov 20, 2026, 1:15 PM CST

Level Biotechnology Revenue

Level Biotechnology had revenue of 186.06M TWD in the quarter ending September 30, 2026, a decrease of -7.03%. This brings the company's total for the last twelve months to 695.30M, down -7.70% year-over-year. In the year 2025, Level Biotechnology had annual revenue of 736.59M with 0.72% growth. That makes Level Biotechnology the 33,592nd largest company in the world by revenue and 1,736th in Taiwan.

Revenue (ttm)
695.30M
Revenue Growth
-7.70%
P/S Ratio
1.33
Revenue / Employee
5.43M
Employees
128
Market Cap
921.66M

Revenue Chart

Revenue by Segment

  • Reagent Consumable Materials Trading 370.01M 50.2%
  • Instrument and Equipment Trading 239.73M 32.5%
  • Entrusted Biotechnology Service Sales 126.86M 17.2%
Fiscal year ended Dec 31, 2025 See the full Level Biotechnology breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025736.59M5.25M0.72%
Dec 31, 2024731.35M70.74M10.71%
Dec 31, 2023660.61M67.60M11.40%
Dec 31, 2022593.01M-84.27M-12.44%
Dec 31, 2021677.28M4.79M0.71%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.